Shanghai and San Diego-based Ablaze Pharmaceuticals, a clinical-stage company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, announced…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.